vir
EMA begin review of GSK & Vir COVID-19 treatment
May 10, 2021Sales and Marketing COVID-19, EMA, GSK, covid-19 treatment, pharma, pharma news, vir
The EMA has begun a rolling review of GSK and Vir’s sotrovimab treatment for COVID-19, which will continue until there …
EMA to begin review of GSK and Vir’s COVID-19 treatment
April 16, 2021Medical Communications COVID-19, EMA, GSK, covid-19 treatment, pharma, pharma news, vir
The EMA have begun a review of GSK and Vir Biotechnology’s investigational COVID-19 antibody (VIR-7831) for patients at high risk …
GSK & Vir’s COVID-19 treatment shows 85% efficacy in Phase III trial
March 29, 2021Sales and Marketing COVID-19, GSK, Phase III trial, covid-19 treatment, vir
GSK and Vir Biotechnology have submitted an Emergency Use Authorization request to the FDA for their VIR-7831 therapy for the …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
September 25, 2026
One in three UK women with migraine say symptoms taken less seriously
September 24, 2026
Report highlights scope to expand day surgery
September 23, 2026
Sygnature formalises drug discovery collaboration with X-Chem
September 22, 2026
Codis appoints Steven Facer as chief commercial officer
September 21, 2026
